Trial · NCT00654927
Adverse events152
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 152
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Adverse Drug Reaction | General disorders | Fampridine-SR b.i.d. (Twice Daily) | 19 | 177 | 26 |
| other | Anxiety | Psychiatric disorders | Fampridine-SR b.i.d. (Twice Daily) | 13 | 177 | 13 |
| other | Arthralgia | Musculoskeletal and connective tissue disorders | Fampridine-SR b.i.d. (Twice Daily) | 34 | 177 | 49 |
| other | Asthenia | General disorders | Fampridine-SR b.i.d. (Twice Daily) | 32 | 177 | 44 |
| other | Back Pain | Musculoskeletal and connective tissue disorders | Fampridine-SR b.i.d. (Twice Daily) | 30 | 177 | 48 |
| other | Balance Disorder | Nervous system disorders | Fampridine-SR b.i.d. (Twice Daily) | 17 | 177 | 24 |
| other | Blood Cholesterol Increased | Investigations | Fampridine-SR b.i.d. (Twice Daily) | 13 | 177 | 15 |
| other | Blood Creatine Phosphokinase Increased | Investigations | Fampridine-SR b.i.d. (Twice Daily) | 11 | 177 | 14 |
| other | Blood Triglycerides Increased | Investigations | Fampridine-SR b.i.d. (Twice Daily) | 9 | 177 | 9 |
| other | Bronchitis | Infections and infestations | Fampridine-SR b.i.d. (Twice Daily) | 10 | 177 | 14 |
| other | Cataract | Eye disorders | Fampridine-SR b.i.d. (Twice Daily) | 10 | 177 | 16 |
| other | Cellulitis | Infections and infestations | Fampridine-SR b.i.d. (Twice Daily) | 9 | 177 | 12 |
| other | Constipation | Gastrointestinal disorders | Fampridine-SR b.i.d. (Twice Daily) | 22 | 177 | 30 |
| other | Contusion | Injury, poisoning and procedural complications | Fampridine-SR b.i.d. (Twice Daily) | 20 | 177 | 33 |
| other | Cystitis | Infections and infestations | Fampridine-SR b.i.d. (Twice Daily) | 9 | 177 | 14 |
| other | Depression | Psychiatric disorders | Fampridine-SR b.i.d. (Twice Daily) | 28 | 177 | 29 |
| other | Diarrhoea | Gastrointestinal disorders | Fampridine-SR b.i.d. (Twice Daily) | 18 | 177 | 24 |
| other | Dizziness | Nervous system disorders | Fampridine-SR b.i.d. (Twice Daily) | 29 | 177 | 40 |
| other | Dyspepsia | Gastrointestinal disorders | Fampridine-SR b.i.d. (Twice Daily) | 10 | 177 | 14 |
| other | Dyspnoea | Respiratory, thoracic and mediastinal disorders | Fampridine-SR b.i.d. (Twice Daily) | 14 | 177 | 18 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00654927/events